Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE229935 |
microRNA profile in the serum of the cervical neoplasia
|
6 | Satoshi Kondo | Apr 18, 2024 | ||||
GSE244347 |
Exploring the usefulness of urinary microRNA as a biomarker in pancreatic cancer and gastric cancer patients.
|
3 | Satoshi Kondo | Apr 01, 2024 | ||||
GSE212211 |
Development of blood biomarkers that distinguish pancreatic cancer from biliary tract cancer
|
426 | Satoko Takizawa | Jun 30, 2023 | ||||
GSE235028 |
Integrated extracellular microRNA profiling for uterine sarcomas
|
30 | Kosuke Yoshida | Jun 15, 2023 | ||||
GSE201712 |
Serum miRNA as Potential Biomarkers for ovarian cancer
|
2 | Satoshi Kondo | Apr 27, 2023 | ||||
GSE217849 |
Effects of (−)-Epigallocatechin-3-O-gallate (EGCG) on miRNAs’ expression in extracellular vesicles (EVs) derived from human umbilical vein endothelial cells (HUVECs)
|
6 | Yuki Marugame | Feb 15, 2023 | ||||
GSE110317 |
The development of a prediction model using serum microRNAs for evaluating axillary lymph node metastasis in breast cancer
|
958 | Ichikawa Makiko | Feb 13, 2023 | ||||
GSE189045 |
The expression profiles of exosomal miRNAs associated with response to anti-PD-1/PD-L1 monotherapy in advanced NSCLC patients.
|
23 | Satoshi Kondo | Jan 12, 2023 | ||||
GSE211692 |
Prediction of tissue-of-origin of early-stage cancers using serum miRNomes
|
16190 | Satoko Takizawa | Nov 12, 2022 | ||||
GSE122426 |
Serum microRNAs as biomarkers for the therapeutic response to trastuzumab/pertuzumab/taxane therapy in HER2-positive metastatic breast cancer
|
30 | Ichikawa Makiko | Nov 04, 2022 | ||||
GSE201359 |
Microarray analysis of serum microRNAs for the detection of urothelial cancer and for the elucidation of cancer development mechanisms
|
178 | Satoko Takizawa | Oct 12, 2022 | ||||
GSE201775 |
Study of microRNA associated with lenvatinib’s anti-tumor effect in hepatocellular carcinoma cell line
|
10 | Satoshi Kondo | Sep 21, 2022 | ||||
GSE209611 |
MicroRNA and mRNA expression profiles of hepatobiliary tumor patients' tissue together with those of non-tumor part tissues and serum exosomes. (miRNA)
|
72 | Satoko Takizawa | Sep 16, 2022 | ||||
GSE209875 |
MicroRNA and mRNA expression profiles of hepatobiliary tumor patients' tissue together with those of non-tumor part tissues and serum exosomes.
|
80 | Satoko Takizawa | Sep 16, 2022 | ||||
GSE151762 |
MicroRNAs changed in response to HDGF treatment
|
4 | Satoshi Kondo | Jun 01, 2022 | ||||
GSE140249 |
Distinct serum microRNA profiles in patients with active autoimmune hepatitis
|
142 | Satoko Takizawa | Apr 27, 2022 | ||||
GSE167559 |
Dementia subtype prediction models constructed by penalized regression methods for multiclass classification using serum microRNA expression data
|
84 | Yuya Asanomi | Oct 22, 2021 | ||||
GSE120181 |
Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment
|
2 | Aya Naiki-Ito | Aug 30, 2021 | ||||
GSE155177 |
IgG4-ROD and orbital MALT lymphoma
|
49 | Satoshi Kondo | Aug 01, 2021 | ||||
GSE164174 |
A novel combination of serum microRNAs for the detection of early gastric cancer
|
2934 | Satoko Takizawa | Jun 23, 2021 |